The JNK/c-Jun cascade and Alzheimer's disease

American Journal of Alzheimer's Disease and other Dementias

Volumn 17, Issue 2, 2002, Pages 79-88

  Okazawa, Hitohi ^a,b   Estus, Steven ^c  

^a UNIVERSITY OF TOKYO   (Japan)

^b TOKYO METROPOLITAN INSTITUTE OF MEDICAL SCIENCE   (Japan)

^c UNIVERSITY OF KENTUCKY   (United States)

Author keywords

Alzheimer's disease; Amyloid; c Jun; c Jun N terminal kinase (JNK); CDK5; Cell death; GSK 3; Neuron; Phosphorylation; Presenilin; SAPK; Tau; Transcription

Indexed keywords

CYCLIN DEPENDENT KINASE 5; PRESENILIN 1; PROTEIN C JUN; STRESS ACTIVATED PROTEIN KINASE; TAU PROTEIN;

ALZHEIMER DISEASE; AMYLOIDOSIS; ARTICLE; BRAIN CELL; CELL ACTIVATION; CELL DEATH; ENZYME ANALYSIS; ENZYME BINDING; GENE ISOLATION; HUMAN; MOLECULAR MECHANICS; NERVE CELL; PATHOLOGICAL ANATOMY; PATHOPHYSIOLOGY; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION;

EID: 0036309739     PISSN: 15333175     EISSN: None     Source Type: Journal    
DOI: 10.1177/153331750201700209     Document Type: Article

References (114)

1. Uber eine eigenartige erkrankung der hirnrinde
2. Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease
3. Genetic linkage evidence for a familial Alzheimer's disease locus on chromosome 14
4. Cloning of a novel gene bearing missense mutations in early onset familial Alzheimer disease
5. Candidate gene for the chromosome 1 familial Alzheimer's disease locus
6. Apolipoprotein E: High-avidity binding to β-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease
7. Alpha-2 macroglobulin is genetically associated with Alzheimer disease
8. Genetic association of the low-density lipoprotein receptor-related protein gene (LRP), an apolipoprotein E receptor, with late-onset Alzheimer's disease
9. Evidence for genetic linkage of Alzheimer's disease to chromosome 10q
10. Linkage of plasma Aβ 42 to a quantitative locus on chromosome 10 in late-onset Alzheimer's disease pedigrees
11. Susceptibility locus for Alzheimer's disease on chromosome 10
12. Interaction between amyloid precursor protein and presenilins in mammalian cells: Implication for the pathogenesis of Alzheimer's disease
13. Presenilin-1 binds to amyloid precursor protein directly
14. Formation of stable complexes between two Alzheimer's disease products: Presenilin-2 and beta-amyloid precursor protein
15. Visualization of Aβ 42(43) and Aβ 40 in senile plaques with end-specific Aβ monoclonals: Evidence that an initially deposited species is Aβ 42(43)
16. Alzheimer's disease: Genes, proteins, and therapy
17. Presenilin-1 is linked with γ-secretase activity in the detergent solublized state
18. Deficiency of presenilin-1 inhibits the normal cleavage of amyloid precursor protein
19. A presenilin-1-dependent γ-secretase-like protease mediates release of Notch intracellular domain
20. Two transmembrane aspartates in presenilin-1 required for presenilin endoproteolysis and γ-secretase activity
21. Total inactivation of γ-secretase activity in presenilin-deficient embryonic stem cells
22. Presenilins are required for γ-secretase cleavage of β-APPP and transmembrane cleavage of Notch-1
23. Photoactivated γ-secretase inhibitors directed to the active site covalently label presenilin-1
24. Presenilins and γ-secretase: Structure meets function
25. Nicastrin modulates presenilin-mediated notch/glp-1 signal transduction and APP processing
26. The role of presenilins in γ-secretase activity: Catalyst or cofactor?
27. The multiple paradozes of presenilins
28. Presenilin-1 differentially facilitates endoproteolysis of the β-amyloid precursor protein and Notch
29. New protease inhibitors prevent γ-secretase-mediated production of Aβ 40/42 without affecting Notch cleavage
30. Binding partners of Alzheimer's disease proteins: Are they physiologically relevant?
31. Immunization with amyloid-β attenuates Alzheimer-disease-like pathology in the PDAPP mouse
32. Aβ peptide immunization reduces behavioural impairment and plaques in a model of Alzheimer's disease
33. Aβ vaccination prevents memory loss in an animal model of Alzheimer's disease
34. Peripherally administered antibodies against amyloidβ-peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer disease
35. Amyloid deposition as the central event in the aetiology of Alzheimer's disease
36. Alzheimer's disease: The amyloid cascade hypothesis
37. Amyloid, the presenilins and Alzheimer's disease
38. Age-dependent emergence and progression of a tauopathy in transgenic mice overexpressing the shortest human tau isoform
39. Neurodegenerative tauopathies
40. Genetic dissection of Alzheimer's disease and related dementias: Amyloid and its relationship to tau
41. PHF and PHF-like fibrils- Cause or consequence?
42. Tauopathy in drosophila: Neurodegeneration without neurofibrillary tangles
43. Targeting small Aβ oligomers: The solution to an Alzheimer's conundrum?
44. Intraneural Aβ 42 accumulation in human brain
45. The oligomerization of amyloidβ-protein begins intracellularly in cells derived from human brain
46. Aβ 42-positive non-pyramidal neurons around amyloid plaques in Alzheimer's disease
47. JNK activation is associated with intracellular β-amyloid accumulation
48. Immunological evidence of oxidative stress in Alzheimer's disease
49. Advanced Maillard reaction products are associated with Alzheimer disease pathology
50. Advanced glycation end products contribute to amyloidosis in Alzheimer disease
51. Hydrogen peroxide mediates amyloidβ protein toxicity
52. Alterations in calcium content and biochemical processes in cultured skin fibroblasts from aged and Alzheimer donors
53. β-amyloid peptides destabilize calcium homeostasis and render human cortical neurons vulnerable to excitotoxicity
54. Increased vulnerability of hippocampal neurons to excitotoxic necrosis in presenilin-1 mutant knock-in mice
55. A cdc2-related kinase PSSALRE/cdk5 is homologous with the 30kDa subunit of tau protein kinase II, a proline-directed protein kinase associated with microtuble
56. Abnormal Alzheimer-like phosphorylation of tau-protein by cyclin-dependent kinases cdk2 and cdk5
57. Precursor of cdk5 activator, the 23 kDa subunit of tau protein kinase II: Its sequence and developmental change in brain
58. Conversion of p35 to p24 deregulates Cdk5 activity and promotes neurodegeneration
59. Glycogen synthetase kinase-3 induces Alzheimer's disease-like phosphorylation of tau: Generation of paired helical filament epitopes and neuronal localization of the kinase
60. Protein kinase FA/GSK-3 phosphorylates tau on Ser 235-Pro and Ser 404-Pro that are abnormally phosphorylated in Alzheimer's disease brain
61. Presenilin 1 associates with glycogen synthetase kinase 3beta and its substrate tau
62. Phosphorylation of microtubule-associated protein tau by stress-activated protein kinases
63. Stress-activated protein kinase/c-Jun N-terminal kinase phosphorylates tau protein
64. Phosphorylation of microtuble-associated protein tau by stress-activated protein kinases
65. Activation and redistribution of c-Jun N-terminal kinase/stress activated protein kinase in degenerating neurons in Alzheimer's disease
66. c-Jun contributes to amyloidβ-induced neuronal apoptosis but is not necessary for amyloidβ-induced c-jun induction
67. Increased immunoreactivity for Jun- and Fos-related proteins in Alzheimer's disease: Association with pathology
68. Expression of Fos, Jun, and Krox family proteins in Alzheimer's disease
69. Quantitative neuronal c-fos and c-jun expression in Alzheimer's disease
70. Presenilin-1 suppresses the function of c-jun homodimers via intgeraction with QM/Jif-1
71. Negative regulation of SAPK/JNK signaling pathway by presenilin 1
72. Presenilin-1 mutations down-regulate the signalling pathway of the unfolded-protein response
73. A role for presenilin-I in nuclear accumulation of Ire 1 fragments and induction of the mammalian unfolded protein response
74. Up-regulation of BiP and CHOP by the unfolded protein response is independent of presenilin expression
75. Presenilin and the UPR
76. Coupling of stress in the ER to activation of JNK protein kinases by transmembrane protein kinase IRS1
77. The upstream stimulatory factor functionally interacts with the Alzheimer amyloidβ-protein precursor gene
78. Cell death during development of the nervous system
79. Effects of long-term nerve growth factor deprivation on the nervous system of the adult rat: An experimental approach
80. Temporal analysis of events associated with programmed cell death (apoptosis) of sympathetic neurons deprived of nerve growth factor (NGF)
81. Characterization of apoptosis in cultured rat sympathetic neurons after nerve growth factor withdrawal
82. Inhibitors of protein synthesis and RNA synthesis prevent neuronal death caused by nerve growth factor deprivation
83. Superoxide dismutase delays neuronal apoptosis: A role for reactive oxygen species in programmed neuronal death of protects sympathetic neurons from NGF deprivation induced apoptosis
84. Expression of human copper/zinc-superoxide dismutase inhibits the death of rat sympathetic neurons caused by withdrawal of nerve growth factor
85. Altered gene expression in neurons during programmed cell death: Identification of c-Jun as necessary for neuronal apoptosis
86. A c-Jun dominant negative mutant protects sympathetic neurons against programmed cell death
87. Genetic and metabolic status of NGF-deprived sympathetic neurons saved by an inhibitor of ICE-family protease
88. Caspase inhibition extends the commitment to neuronal death beyond cytochrome c release to the point of mitochondrial depolarization
89. Inhibition of apoptotic signaling cascades causes loss of trophic factor dependence during neuronal maturation
90. Role of the Jun kinase pathway in the regulation of c-Jun expression and apoptosis in sympathetic neurons
91. Direct inhibition of c-Jun N-terminal kinase in sympathetic neurones prevents c-Jun promoter activation and NGF withdrawal-induced death
92. The role of Jun-kinases in apoptosis
93. Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis
94. CEP-1347 (KT7515), an inhibitor of JNK activation, rescues sympathetic neurons and neuronally differentiated PC12 cells from death evoked by three distinct insults
95. JNK3 contributes to c-Jun activation and apoptosis but not oxidative stress in nerve growth factor-deprived sympathetic neurons
96. Amino-terminal phosphorylation of c-Jun regulates stress-induced apoptosis and cellular proliferation
97. Induction of BIM, a proapoptotic BH3-only Bcl-2 family member, is critical for neuronal apoptosis
98. Dominant-negative c-Jun promotes neuronal survival by reducing BIM expression and inhibiting mitochondrial cytochrome c release
99. BH3-only Bcl-2 family members are coordinately regulated by the JNK pathway and require Bax to induce apoptosis in neurons
100. Evidence of a novel event during neuronal death: Development of competence-to-die in response to cytoplasmic cytochrome C
101. Apoptosis mediated neurotoxicity induced by chronic application of β-amyloid fragment 25-35
102. Apoptosis is induced by Aβ-amyloid in cultured central nervous system neurons
103. Ultrastructural analysis of beta-amyloid-induced apoptosis in cultured hippocampal neurons
104. Aggregated amyloid-β protein induces cortical neuronal apoptosis and concomitant apoptotic pattern of gene induction
105. In vitro aging of β-amyloid protein causes peptide aggregation and neurotoxicity
106. Secondary structure of amyloid beta peptide correlates with neurotoxic activity in vitro
107. Differential induction of immediate early gene proteins in cultured neurons by β-amyloid (Aβ): Association of c-Jun with Aβ induced apoptosis
108. β-amyloid-induced neuronal apoptosis requires c-Jun N-terminal kinase activation
109. Absence of excitotoxicity-induced apoptosis in the hippocampus of mice lacking the Jnk3 gene
110. Enhanced neurofibrillary degeneration in transgenic mice expressing mutant tau and APP
111. APPSw transgenic mice develop age-related A beta deposits and neuropil abnormalities, but no neuronal loss in CAI
112. Treatment with a copper-zinc chelator markedly and rapidly inhibits β-amyloid accumulation in Alzheimer's disease transgenic mice
113. CEP-1347/KT-7515, an inhibitor of SAPK/JNK pathway activation, promotes survival and blocks multiple events associated with Aβ-induced cortical neuron apoptosis
114. Selective small-molecule inhibitors of glycogen synthetase kinase-3 activity protect neurones from death